Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

124.60 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,923
Open 124.60
Bid (Size) 126.15 (2)
Ask (Size) 126.25 (4)
Prev. Close 124.60
Today's Range 124.60 - 124.60
52wk Range 91.51 - 124.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Healthcare Stocks That Could Set You Up For Life
All offer products that are invaluable to their respective audiences. 
Via The Motley Fool
Novo Nordisk To Invest Over DKK5B To Add API Production Capacity To Danish Plant
 
Via Benzinga

Performance

YTD
+14.53%
+14.53%
1 Month
+14.48%
+14.48%
3 Month
+17.44%
+17.44%
6 Month
+12.93%
+12.93%
1 Year
+16.63%
+16.63%

More News

Read More
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
Via Benzinga
Medical Tech Company Concludes Successful Uplist to NYSE American
Via Benzinga
Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads
Via Investor's Business Daily
Novo Nordisk (NVO) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Novo Nordisk Raises FY22 Earnings Outlook On Robust Ozempic Sales
Via Benzinga
Prediction: This Could Be This Company's Next Billion-Dollar Product
Via The Motley Fool
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It
Via Investor's Business Daily
How Amgen Is Closing In On Rivals Novo Nordisk, Eli Lilly With Obesity Drug
Via Investor's Business Daily
Why Teva Stock Stumbled Again on Friday
Via The Motley Fool
3 Unstoppable Investments Everyone Needs in Their Portfolio
Via The Motley Fool
Novo Nordisk Joins NLRP3 Bandwagon, Bets $70M On Ventus' Lead Drug Candidate
Via Benzinga
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
Via Benzinga
Why Novo Nordisk A/S Shares Are Shooting Higher Today
Via Benzinga
Novo Nordisk Is Throwing Down The Gauntlet In Weight Loss As Eli Lilly Ramps Up
Via Investor's Business Daily
Novo Nordisk: Q3 Earnings Insights
Via Benzinga
The 7 Best Mutual Funds for Your 401(k)
Via InvestorPlace
Amgen Shares Leap Higher On Upbeat Outlook For Obesity Treatment
Via MarketBeat
Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants
Via Benzinga
Biotech Stocks Well-Positioned For The Fourth Quarter
Via Talk Markets
Amgen, The Big Name You Need To Know Going Up Against Novo, Lilly In Obesity
Via Investor's Business Daily
Global Exposure: Value Or Value Trap?
Via Talk Markets
Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.